All Releases
 |
Micrus Endovascular Reports Broad-Based Strength in Fiscal Second Quarter Revenues
Oct 6, 2008
|
13.2 KB |
| |
SAN JOSE, Calif., Oct 06, 2008 (BUSINESS WIRE) -- Micrus Endovascular Corporation (Nasdaq:MEND) today announced that revenues for the second quarter of fiscal year 2009 are expected to range between $20.5 million to $20.8 million. This represents an increase of 43% to 45% compared with the second quarter of fiscal year 2008 and an increase of 12% t...
|
|
Micrus Endovascular Announces Launch of Innovative DeltaPaq Microcoil System
Sep 23, 2008
|
12.4 KB |
| |
SAN JOSE, Calif., Sep 23, 2008 (BUSINESS WIRE) -- Micrus Endovascular Corporation (Nasdaq:MEND) today announced the initiation of its launch of Cerecyte(R) and stretch resistant versions of its DeltaPaq(TM) microcoil system for the treatment of cerebral aneurysms. The novel DeltaPaq system is designed to achieve 10% to 20% greater intra-aneurysmal ...
|
|
Micrus Endovascular to Present at Investment Conferences
Sep 18, 2008
|
11.0 KB |
| |
SAN JOSE, Calif., Sep 18, 2008 (BUSINESS WIRE) -- Micrus Endovascular Corporation (NASDAQ:MEND) today announced that John Kilcoyne, Micrus Chairman and CEO, will make presentations at two upcoming investment conferences:
-- UBS Global Life Sciences Conference on Thursday, September 25, at 9:00 a.m. Eastern time, which will be held at the Grand ...
|
|
Micrus Endovascular Launches Neuropath Guide Catheter
Sep 16, 2008
|
12.6 KB |
| |
SAN JOSE, Calif., Sep 16, 2008 (BUSINESS WIRE) -- Micrus Endovascular Corporation (Nasdaq: MEND) today announced the initiation of its worldwide launch of Neuropath(R) guide catheter line. The launch of the Neuropath guide catheter demonstrates Micrus' continued commitment to a more broadly based product portfolio and the development of novel acces...
|
|
Micrus Endovascular Reports First Quarter Financial Results
Aug 7, 2008
|
20.5 KB |
| |
SAN JOSE, Calif., Aug 07, 2008 (BUSINESS WIRE) -- Micrus Endovascular Corporation (Nasdaq:MEND) today reported financial results for the three months ended June 30, 2008.
Revenues for the first quarter of fiscal year 2009 were $18.3 million, up 9% compared with revenues of $16.8 million for the first quarter of fiscal year 2008 primarily due to...
|
|
Micrus Endovascular to Hold 2009 First Quarter Conference Call on August 7
Jul 29, 2008
|
11.2 KB |
| |
SAN JOSE, Calif., Jul 29, 2008 (BUSINESS WIRE) -- Micrus Endovascular Corporation (Nasdaq:MEND) today announced that it will release financial results for the quarter ended June 30, 2008, on Thursday, August 7, 2008. Micrus' management will host an investment community conference call at 10:30 a.m. Eastern time (7:30 a.m. Pacific time) to discuss t...
|
|
Micrus Endovascular Receives FDA Approval for Intracranial Stent Clinical Trial
Jul 14, 2008
|
13.0 KB |
| |
SAN JOSE, Calif., Jul 14, 2008 (BUSINESS WIRE) -- Micrus Endovascular Corporation (Nasdaq:MEND) today announced that the Vitesse Intracranial Stent Study for Ischemic Therapy (VISSIT) clinical trial application has been conditionally approved by the U.S. Food and Drug Administration (FDA). The Pharos(TM) Vitesse(TM) intracranial stent is Micrus End...
|
|
Micrus Endovascular Receives Approval to Market Cerecyte Microcoils in Japan
Jul 10, 2008
|
12.2 KB |
| |
SAN JOSE, Calif., Jul 10, 2008 (BUSINESS WIRE) -- Micrus Endovascular Corporation (Nasdaq: MEND) today announced receipt of Shonin approval from the Ministry of Health, Labour and Welfare (MHLW) to market in Japan its Cerecyte(R) microcoil product line, including the MicruSphere(R), Presidio(R), HeliPaq(R) and UltiPaq(R) Cerecyte embolic coils, for...
|
|
Micrus Endovascular Announces CE Mark for PHAROS Vitesse Stent
Jun 23, 2008
|
13.1 KB |
| |
SAN JOSE, Calif., Jun 23, 2008 (BUSINESS WIRE) -- Micrus Endovascular Corporation (Nasdaq: MEND) today announced that its PHAROS(TM) Vitesse(TM) intracranial stent has received CE Mark authorization for commercial distribution in the European Union and all countries recognizing the CE Mark. The PHAROS Vitesse is Micrus Endovascular's balloon-expand...
|
|
Micrus Endovascular to Present at 2nd Annual Jefferies Healthcare Conference
Jun 19, 2008
|
10.8 KB |
| |
SAN JOSE, Calif., Jun 19, 2008 (BUSINESS WIRE) -- Micrus Endovascular Corporation (NASDAQ:MEND) today announced that Robert Stern, President and COO, will present at the Jefferies 2nd Annual Healthcare Conference on Thursday, June 26 at 1:00 p.m. Eastern time (10:00 a.m. Pacific time).
A live audio webcast of the conference presentation will be...
|
|
Micrus Endovascular to Present at 7th Annual Needham & Company Biotechnology & Medical Technology Conference
Jun 5, 2008
|
11.2 KB |
| |
SAN JOSE, Calif., Jun 05, 2008 (BUSINESS WIRE) -- Micrus Endovascular Corporation (NASDAQ: MEND) today announced that John Kilcoyne, Chairman and CEO, will present at the 7th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference on Wednesday, June 11 at 10:30 a.m. Eastern time (7:30 a.m. Pacific time).
A live audio and sli...
|
|
Positive Clinical Data Evaluating the Micrus Endovascular Cerecyte Microcoil Published in Peer-Reviewed Journals
Jun 5, 2008
|
14.8 KB |
| |
SAN JOSE, Calif., Jun 05, 2008 (BUSINESS WIRE) -- Micrus Endovascular Corporation (Nasdaq: MEND) today announced that positive data from two clinical studies evaluating the use of the Micrus Endovascular Cerecyte(R) bioactive microcoil in the treatment of cerebral aneurysms have been published in peer-reviewed scientific journals. Cerecyte platinum...
|
|
Micrus Endovascular to Present at May Investment Conferences
May 14, 2008
|
11.0 KB |
| |
SAN JOSE, Calif., May 14, 2008 (BUSINESS WIRE) -- Micrus Endovascular Corporation (NASDAQ:MEND) today announced that management will make presentations at three investment conferences in May:
-- Robert Stern, Micrus President and COO, will present at the Citigroup Healthcare Conference on Wednesday, May 21, at 8:00 a.m. Eastern time. The confer...
|
|
Micrus Endovascular Fourth Quarter Revenues Increase 23%
May 8, 2008
|
21.8 KB |
| |
SAN JOSE, Calif., May 08, 2008 (BUSINESS WIRE) -- Micrus Endovascular Corporation (Nasdaq:MEND) today announced financial results for the three months and fiscal year ended March 31, 2008, and provided fiscal 2009 revenue guidance.
Micrus reported revenues for the fourth quarter of fiscal 2008 of $19.7 million, an increase of 23% compared with ...
|
|
Micrus Endovascular to Hold 2008 Fourth Quarter and Full Year Conference Call on May 8
Apr 30, 2008
|
11.2 KB |
| |
SAN JOSE, Calif., Apr 30, 2008 (BUSINESS WIRE) -- Micrus Endovascular Corporation (Nasdaq: MEND) today announced that it will release financial results for the quarter and fiscal year ended March 31, 2008, and introduce fiscal 2009 financial guidance before market open on Thursday, May 8, 2008. Micrus' management will host an investment community c...
|
|
Micrus Endovascular and Chemence Medical Products Sign Development Agreement for Liquid Embolic Products
Apr 23, 2008
|
13.8 KB |
| |
SAN JOSE, Calif. & ALPHARETTA, Ga., Apr 23, 2008 (BUSINESS WIRE) -- Micrus Endovascular Corporation (Nasdaq:MEND) and privately held Chemence Medical Products, Inc. today announced the signing of an exclusive agreement to jointly develop liquid embolic products for neurovascular indications using Chemence's cyanoacrylate technology, development cap...
|
|
Micrus Endovascular to Present at March Investment Conferences
Feb 28, 2008
|
11.2 KB |
| |
SAN JOSE, Calif., Feb 28, 2008 (BUSINESS WIRE) -- Micrus Endovascular Corporation (Nasdaq: MEND) today announced that management will make presentations at four investment conferences in March:
-- Robert Stern, Micrus President and COO, will present at the Rodman & Renshaw "Straight to the Heart" one-day, one-on-one meeting conference on Tuesda...
|
|
Micrus Endovascular Reports 18% Third Quarter Revenue Growth
Feb 7, 2008
|
19.3 KB |
| |
SAN JOSE, Calif., Feb 07, 2008 (BUSINESS WIRE) -- Micrus Endovascular Corporation (Nasdaq:MEND) today announced financial results for the three and nine months ended December 31, 2007.
Micrus reported revenues of $18.3 million for the third quarter of fiscal 2008, an increase of 18% compared with revenues of $15.5 million for the third quarter ...
|
|
Micrus Endovascular to Hold 2008 Third Quarter Conference Call on February 7
Jan 29, 2008
|
9.3 KB |
| |
SAN JOSE, Calif., Jan 29, 2008 (BUSINESS WIRE) -- Micrus Endovascular Corporation (Nasdaq: MEND) today announced that it will release financial results for the quarter ended December 31, 2007 before market open on Thursday, February 7, 2008. Micrus' management will host an investment community conference call at 10:30 a.m. Eastern time (7:30 a.m. P...
|
|
Micrus Endovascular and Genesis Medical Interventional Sign License, Development and Commercialization Agreement
Jan 17, 2008
|
12.0 KB |
| |
SAN JOSE & REDWOOD CITY, Calif., Jan 17, 2008 (BUSINESS WIRE) -- Micrus Endovascular Corporation (Nasdaq:MEND) and privately held Genesis Medical Interventional, Inc. today announced that they have entered into an agreement granting Micrus the rights to Genesis' F.A.S.T.(TM) Funnel Catheter(TM) and clot retrieval system for the treatment of ischemi...
|
|
|
